Receipt of Statins Is Associated With Lower Risk of Multiple Myeloma: Systematic Review and Meta-analysis

Data on receipt of statins and risk of multiple myeloma (MM) are still conflicting. We performed a systematic review that comprised terms for “statin” and “multiple myeloma” and identified 10 eligible studies for meta-analysis. The risk of MM was significantly lower among statin recipients than those who did not receive statins.

Source: Clinical Lymphoma, Myeloma and Leukemia - February 25, 2020 Category: Hematology Authors: Ben Ponvilawan, Nipith Charoenngam, Thanitsara Rittiphairoj, Patompong Ungprasert Tags: Original Study Source Type: research